Canada markets open in 8 hours 33 minutes

WuXi Biologics (Cayman) Inc. (2269.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
44.200-1.450 (-3.18%)
As of 11:59AM HKT. Market open.
Currency in HKD

Valuation Measures4

Market Cap (intraday) 193.95B
Enterprise Value 190.14B
Trailing P/E 44.91
Forward P/E 24.45
PEG Ratio (5 yr expected) 1.13
Price/Sales (ttm)11.23
Price/Book (mrq)4.80
Enterprise Value/Revenue 11.49
Enterprise Value/EBITDA 37.45

Trading Information

Stock Price History

Beta (5Y Monthly) 1.23
52-Week Change 3-9.33%
S&P500 52-Week Change 313.11%
52 Week High 377.400
52 Week Low 335.000
50-Day Moving Average 343.037
200-Day Moving Average 349.280

Share Statistics

Avg Vol (3 month) 317.31M
Avg Vol (10 day) 315.78M
Shares Outstanding 54.25B
Implied Shares Outstanding 64.25B
Float 83.65B
% Held by Insiders 114.07%
% Held by Institutions 147.15%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 23:1
Last Split Date 3Nov 16, 2020

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Jun 30, 2023

Profitability

Profit Margin 25.08%
Operating Margin (ttm)25.18%

Management Effectiveness

Return on Assets (ttm)5.23%
Return on Equity (ttm)11.45%

Income Statement

Revenue (ttm)16.55B
Revenue Per Share (ttm)3.98
Quarterly Revenue Growth (yoy)17.80%
Gross Profit (ttm)N/A
EBITDA 4.83B
Net Income Avi to Common (ttm)4.15B
Diluted EPS (ttm)1.050
Quarterly Earnings Growth (yoy)-10.60%

Balance Sheet

Total Cash (mrq)8.69B
Total Cash Per Share (mrq)2.05
Total Debt (mrq)5.34B
Total Debt/Equity (mrq)13.67%
Current Ratio (mrq)2.20
Book Value Per Share (mrq)8.88

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A